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Cellular calcium either directly controls, or at a minimum modulates nearly, if not, all 
human functions. As such, the structural motif that forms the calcium binding pocket (EF-hand) is 
one of the most common protein elements found in Mammalia. The calcium binding properties of 
the EF-hands appear to be “tuned” to receive and respond to different calcium signals and can vary 
by over 6 orders of magnitude. Our laboratory is attempting to understand the rules that govern 
calcium binding to proteins, so that we might be able to engineer these proteins as gene therapies 
to treat diseases. Calmodulin is a small, switch-like, calcium binding protein that plays multiple 
roles in all human cells depending on what protein system it is attached. We are using rational 
design, super computers as well as evolutionary clues to help us engineer calmodulins with specific 
functionalities. Using a simple mathematical model to describe the calcium binding events of 
calmodulin and available steady-state and kinetic data, we determined the exact rate parameters 
that govern this interaction for wild type calmodulin and other variants (such as plant calmodulins, 
disease mutants, and engineered calmodulins). Troponin C is the “cousin” of calmodulin and is 
very important in the calcium regulation of muscle contraction. Using a previously created 
mathematical model for the activation of the cardiac troponin complex, we modified the rate 
parameters to effectively simulate the calcium binding data for the slow skeletal isoform and 
characterized the effects of a potential small molecule therapeutic. This information better helps 
us identify what we want to alter in order to achieve a particular outcome (in terms of engineering 
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 In nearly every branch of science, from the physical sciences to the social sciences, the 
concept of modeling is incredibly important. Whether the subject is molecular biology, quantum 
physics, abnormal psychology, or criminology, a model will always be of use to aid in the 
description of systems and their study. In addition to simplifying a system of interest, models can 
be used to perform experiments that may not be feasible for a number of reasons – too costly, too 
risky, or too difficult. Researchers or others may also opt to use a model system to anticipate the 
impacts of an action or experimental modification. Perhaps a demolition crew would like to model 
the impact of their explosives on a building in an empty field before tearing down a building in the 
heart of a city, or perhaps a biochemist would like to anticipate whether an experiment with costly 
reagents is worth pursuing before spending the money. In any sense, a model can be beneficial in 
practically any scenario, and it is clear that models for biochemical systems can aid in the 
understanding of their molecular interactions. 
 When it comes to modeling biochemical interactions, there are several approaches that can 
be taken. One of the most frequently used approaches is modeling a system with molecular 
structures. A molecular structure can be obtained in many different ways – there are the 
experimental approaches of X-ray crystallography, nuclear magnetic resonance, and cryogenic 
electron microscopy, and a structure can also be predicted using the plethora of homology 
modeling software that now exists. If the structure of a protein or nucleic acid is known or 
predicted, researchers can use the model of the macromolecule to make predictions about 
interactions, investigate the potential impacts of mutations, and visualize potential or real 
conformational changes. These structural models are very powerful, allowing the scientist to view 




be made from a mathematical standpoint to simulate the kinetics of a system, which can be used 
to describe binding events in a different fashion than structural models. The advantages of this 
approach are plentiful and distinct from a molecular structure. Firstly, the system of interest can 
be expanded to include more than a structural model. A mathematical model can involve several 
macromolecules and/or several small molecules or ions and can simulate several different binding 
events. Second, a mathematical model can allow other questions to be asked or other aspects of a 
system to be looked at. A mathematical model uses microscopic properties of individual molecules 
to describe binding events that cannot be investigated through structure. The affinity for a target 
cannot be determined by looking at a structure (although it can be estimated or predicted relative 
to similar interactions), but it can be determined using the specifics of a mathematical model. 
Finally, mathematical models are more efficient than most experiments that involve structural 
models. The software required is cheaper, there is less demand in terms of computing power, and 
the experiments simply do not consumer as much time. With the same resources, more work can 
be accomplished in one day with a mathematical model than most experiments that a structural 
model is used for.  
 It is this concept of mathematical modeling that this project is centered around. In the 
context of the calcium binding protein calmodulin (CaM), the protein-ion binding events are useful 
to model to obtain a deeper understanding of the microscopic mechanisms that govern the 
properties of this interaction. Similarly, the calcium binding protein troponin C (TnC), part of the 
troponin complex (Tn), and its interaction with troponin I (TnI), can be effectively modeled to 
understand the specifics of the binding events. Both of these proteins are important for function 




in several disease states, such as arrythmia and various cardiomyopathies. For these reasons, it is 
important to understand them with as much depth as possible.  
Properties of Calmodulin 
 As a protein, CaM is arguably one of the most influential proteins to be characterized and 
researched. CaM is essential for mammalian life, so much so that there are multiple copies of the 
CaM gene in certain organisms to prevent lethal recombination events involving the CaM gene 
(Fischer et al., 1988). CaM is a calcium-binding protein that allows for signals communicated by 
changing calcium levels to be translated into specific cellular and biochemical events (Chin & 
Means, 2000). CaM has hundreds of downstream binding targets, which can include a plethora of 
different protein classes, examples including Myosin Light Chain Kinase (MLCK), Calcineurin 
(CaN), Nitric Oxide Synthase (NOS), and the Ryanodine Receptor (RyR) (Vogel, 1994). 
 CaM is a small protein of 148 amino acid residues, consisting of two domains which create 
a dumbbell shape. The two domains are connected via a flexible linker, allowing for a large amount 
of flexibility within the CaM structure, hence providing the opportunity for the vast array of 
downstream targets for CaM. Each domain contains two calcium binding sites, which are part of 
the EF-hand family, providing four binding motifs in one protein. The EF-hand structural motif 
consists of a helix-loop-helix pattern, where the loop contains amino acids designed to coordinate 
a calcium ion. In addition to binding calcium, CaM is known to competitively bind magnesium 
ions, competing with up to 1 mM free magnesium in the cell (Ohki et al., 1997; Tikunova et al., 
2001; Waters, 2011). In general, the magnesium affinity of the C-terminal domain of CaM is 
physiologically irrelevant (KD > 10 mM), but the affinity for magnesium of the N-terminal domain 




 When CaM binds calcium, it undergoes a conformational change. In the apo state, the 
surface of CaM is hydrophilic and hydrophobic residues are buried, but upon calcium binding, 
hydrophobic pockets are exposed within both the N-terminal and C-terminal domains, which will 
then partake in target binding (Chin & Means, 2000). Interestingly, the CaM-binding domains of 
the many CaM targets do not share sequence similarity. However, this can be a rationalization for 
why CaM can have so many protein targets. The general formula for a CaM-binding domain 
includes basic and hydrophobic residues arranged in an amphipathic alpha helix. This allows for 
CaM’s methionine-rich interior to favorably interact with the targe enzyme and alter function 
within the cell (Vogel, 1994). Evidently, there are many aspects of CaM that can be and deserve 
to be studied, many of which can be aided by the utilization of models.  
 While the C-terminal and N-terminal domains of CaM share structural similarity, their 
calcium binding properties are different. In terms of both steady-state affinity and kinetics, the two 
domains will bind calcium differently, which can help determine a potential method of regulation 
through CaM acting as a calcium sensing switch. For steady-state affinity, both domains have 
calcium affinities in the micromolar range, but the C-terminal domain is more sensitive to calcium 
than the N-terminal domain by approximately 2-3-fold (Walton et al., 2017). Interestingly, the 
kinetics of calcium binding to these domains do not correlate to the affinity difference in all cases. 
The calcium association rate is faster for the N-terminal domain by 1-2 orders of magnitude, which 
would imply a higher calcium affinity for the N-terminal domain (Johnson et al., 1996). However, 
the higher affinity of the C-terminal domain comes from the difference in calcium dissociation 
rates. The calcium dissociation rate of the N-terminal domain is approximately 2 orders of 
magnitude faster than the calcium dissociation rate of the C-terminal domain, so much so that the 




al., 1996). These data imply a potential method of how CaM can act as a calcium sensing switch 
and activate target enzymes based on calcium signals. The affinity of the C-terminal domain for 
calcium is low enough that a significant level of CaM C-terminal domains will be saturated at 
basal calcium levels, hence the C-terminal domain will be in an open conformation and able to 
bind target enzymes. On the other hand, the N-terminal domain’s affinity is too low to hold on to 
calcium at a basal level, but its fast calcium association rate allows for rapid calcium binding 
followed by rapid target enzyme binding and subsequent activation. In essence, the C-terminal 
domain acts an anchor to the target enzyme, and the N-terminal domain acts as the regulator to 
activate the target enzyme when the signal is given (Davis et al., 2016).  
Calmodulin Variants 
Much of the current literature in the field focuses on CaM’s relevance to human health and 
disease, but this protein is not limited to humans, or even animals. While it has been established 
that there is essentially no variance among CaM sequence and structure among vertebrates, plant 
species express many different variants of CaM with differences that can range from a single amino 
acid up to a quarter of the entire protein (McCormack and Braam, 2003; McCormack et al., 2005). 
In addition to the structural variation present between the CaM isoforms found in plants, there is 
also substantial variation in the expression patterns between certain isoforms (Al-Quraan, 2008; 
Park et al., 2009). When it comes to CaM, one of the better characterized plant organisms is the 
soybean. There are two main isoforms in the soybean: soybean CaM 1 (sCaM1) and soybean CaM 
4 (sCaM4). sCaM1 is known as the “housekeeping” CaM, expressed during periods of low stress 
where the plant is functioning as desired. sCaM4 becomes expressed during periods of stress and 
exhibits differential effects from sCaM1. These two isoforms will bind nearly all the same target 




al., 1995, 2000; Cho et al., 1998; Kondo et al., 1999). Interestingly, this phenomenon of isoform-
dependent activation and inhibition is not limited to plant targets. When the soybean CaMs bind 
to human CaN, sCaM1 will activate the phosphatase to a similar level as mammalian CaM, but 
sCaM4’s activation of CaN is decreased compared to the mammalian isoform (Cho et al., 1998).   
The soybean CaMs have more differences between them than their effects on target 
binding. Consistent with mammalian CaM, the C-terminal domain of both soybean isoforms bind 
calcium with approximately four-fold higher affinity than the N-terminal domain (Walton et al., 
2017). In addition, each domain of sCaM4 has a higher affinity for calcium than the domains of 
sCaM1 (Walton et al., 2017). In terms of magnesium affinity, the soybean CaMs follow the same 
pattern as mammalian CaM, with a physiologically relevant N-terminal domain affinity and a 
physiologically irrelevant C-terminal domain affinity (Walton et al., 2017). Between the two 
isoforms there is a similar pattern to the calcium affinity, with sCaM4 having a higher affinity for 
magnesium than sCaM1, however both soybean isoforms have a higher ion affinity than 
mammalian CaM (Walton et al., 2017). In addition to the steady-state differences, there are also 
differences in the kinetics of these two CaMs. The calcium dissociation rates from each domain 
are slower for sCaM4, corresponding to the higher calcium affinity shown by sCaM4. 
Interestingly, the calcium association rates are faster for sCaM1 even though this isoform has a 
lower steady-state affinity (Walton et al., 2017). This interplay between steady-state affinity and 
kinetics is thought-provoking and perhaps demonstrates different methods of regulation by these 
CaMs or insights to the evolutionary driving forces behind their divergence. Comparing the C-
terminal and N-terminal domains in the individual proteins, the pattern of their kinetics is similar 
to mammalian CaM. The N-terminal domain of each soybean CaM has a much higher calcium 




is no available data for the calcium association rates of the C-terminal domains of the soybean 
CaMs, so these rates can only be compared to the calcium association rates of the respective N-
terminal domains if they are calculated based on the KD and the calcium dissociation rate.   
In addition to CaMs in other organisms, it is also interesting to look at artificial variants of 
CaM. One of the primary efforts of the lab is to engineer novel CaMs to bind both calcium and 
target proteins with higher affinity, with the end goal to use a successfully engineered protein as 
treatment for cardiovascular disease. Through in silico protein redesign and molecular dynamics 
simulations, mutations can be pinpointed in CaM that will enhance its efficacy within a certain 
system. Once purified, the engineered CaMs go through a series of biochemical and physiological 
experiments to test whether they act as predicted. The biochemical characterizations, such as 
determining the steady-state calcium affinity and obtaining the kinetics of the engineered CaM, 
are more fundamental and aid in future protein redesign. The physiological characterizations more 
directly establish whether the engineered protein could potentially be therapeutic. The lab has 
made progress on this front, using clues from previous engineered proteins as well as evolutionary 
hints from the soybean CaMs to engineer several CaMs with potential to improve the functioning 
of the biochemical systems that go awry in disease. The current focus is on engineering a CaM to 
bind RyR with high affinity (Bogdanov et al., 2020).  
Previous Calmodulin Models 
 This project is not the first to approach CaM binding events from a mathematical modeling 
standpoint. Other researchers in the field have previously used mathematical models to simulate 
the effects of competition on the differential activation of different CaM downstream binding 
targets. The experiments performed with these models are useful and answer important questions. 




target proteins in isolation, specifically that competition for CaM as a limiting factor with many 
target proteins influences the activation levels of individual targets (Romano et al., 2017). A model 
can also demonstrate the impact of the frequency of calcium oscillations on differential activation 
of multiple CaM binding targets. Depending on the presence or absence of competitive target 
proteins, the activation of specific target proteins, such as CaN or NOS, will be maximal at 
differing frequencies of calcium transients, and the range of optimal frequencies will sharpen 
(Romano et al., 2017; Slavov, Carey, & Linse, 2013). These models also show how the optimal 
oscillation frequency can change given the number of competitors (Slavov, Carey, & Linse, 2013).  
 In addition to demonstrating frequency dependence of differential activation of CaM target 
proteins, models have been used to show how biochemical systems maintain homeostasis in times 
of stress and perturbation. In addition to changes in the activation of different CaM target proteins 
based on the frequency of calcium oscillations, the same effect will be seen if other parameters of 
the system are modified (Romano et al., 2017). Given the observations from these experiments on 
“competitive tuning,” there are a multitude of potential consequences, including some that can be 
particularly relevant to physiology. In the context of a neuron, the most relevant downstream CaM 
binding proteins are involved in neuronal plasticity, and any slight perturbation in one of these 
systems has the potential to have dramatic impacts on neurophysiology. Using a mathematical 
model to describe the calcium binding events of CaM as well as the target protein binding events, 
it has been demonstrated that the competitive tuning that is seen between the target proteins is used 
to provide a compensatory mechanism for perturbations in the system (Pharris, Patel, & Kinzer-
Ursem, 2018). If a CaM target protein is downregulated or knocked out, the system can shift in 




a similar function that leads to the same final outcome as before (Pharris, Patel, & Kinzer-Ursem, 
2018).  
 Evidently, the CaM models in the literature are complex. The incorporation of just one 
target protein into a model can dramatically increase the number of parameters necessary for the 
simulation, yet most of the previous models incorporate multiple. However, with increasing 
complexity also comes simplicity. When the parameter field becomes large with many reactions 
taking place in the simulation, researchers will look for ways to simplify the model in any way that 
they can, and this usually is done with regard to the calcium binding events of CaM. As previously 
stated, each molecule of CaM has four calcium binding sites, which allows for 16 potential 
configurations of the individual sites being bound or unbound, ranging from all unbound to all 
bound. But there are some ways of cutting down on this breadth of possibilities. Firstly, the 
assumption can be made that there is no significant difference between the individual sites within 
each domain. Without the need to distinguish between site 1 and site 2 within a domain, the model 
for calcium binding can be reduced to nine potential configurations (Pepke et al., 2010). This 
model can be further simplified to create a four-state model by ignoring the configurations in which 
only one calcium ion is bound to a domain, only considering the apo state, the calcium saturated 
state, and the states in which one domain is saturated and the other is apo. The rationalization 
behind condensing the individual calcium binding events into a single event comes from the highly 
cooperative nature of the calcium binding (Pepke et al., 2010). To simplify the model to three 
states, a model can be operated under the assumption that the C-terminal domain will always be 
saturated before the N-terminal domain, so the configuration in which the N-terminal domain is 
saturated, and the C-terminal domain is unsaturated is neglected (Slavov, Carey, & Linse, 2013). 




terminal domain has a higher calcium affinity than the N-terminal domain (Walton et al., 2017) 
but neglects to consider that the calcium association rate is much faster for the N-terminal domain 
than the C-terminal domain (Johnson et al., 1996). There is also the possibility of condensing the 
model even further to only two states, an all or nothing model in which CaM is either apo or fully 
saturated with calcium (Pharris, Patel, & Kinzer-Ursem, 2018). 
 Of course, this simplification does not occur without consequence. Clearly, a model with 
more possible states is more biophysically accurate. Comparing the two simplest models, a four-
state model is more sensitive to calcium than a two-state model is (Pharris, Patel, & Kinzer-Ursem, 
2018), indicating that a significant level of biophysical accuracy is lost when the model is 
oversimplified to this degree. Nevertheless, it has been argued that the four-state model has 
negligible differences between the nine-state model (Romano et al., 2017), hence a three-state or 
four-state model has generally been considered to be adequate to simulate the calcium binding 
properties of CaM within the larger-scale model that includes multiple target proteins (Romano et 
al., 2017; Pharris, Patel, & Kinzer-Ursem, 2018; Slavov, Carey, & Linse, 2013).  
However, this simple model may not be accurate enough to effectively model the calcium 
binding in all scenarios. Returning to the idea of cooperativity that was used to simplify the model 
from nine to four states, the cooperativeness of the calcium binding could end up being an issue in 
certain modeling experiments. The nine-state model will take into account the cooperativity of the 
calcium ions, but a four-state model will not. In the experiments previously described in which the 
calcium concentration oscillates between saturating and subsaturating, the cooperativity between 
calcium ions will not have a dramatic effect, as the free calcium concentration is never such that 
CaM will be partially saturated, so the four-state model will be sufficient. But if simulations were 




partially saturated, it is important that cooperativity is considered, because a cooperative model 
will give a level of calcium saturation that can be significantly different than an uncooperative 
model.  
 Due to this situation in which cooperativity can and will have an impact on the level of 
calcium saturation, it is important to have a model that both exhibits the cooperativity required and 
accurately describes the calcium binding events for CaM. This is what the current project aims to 
accomplish. The creation of an accurate and descriptive model can be extraordinarily beneficial to 
the field. It can be incorporated into more complex models that describe CaM’s interactions with 
target proteins, specifically creating a model that can be accurate during subsaturating calcium 
concentrations. It can also be used in the quest to engineer novel CaMs as potential therapeutics, 
potentially allowing for a deeper understanding of the effects certain mutations have on the kinetics 
of calcium binding. With a model that contains a sufficient number of configurations and that is 
accurate, many doors are opened to new experiments, new models, and new information.  
Troponin C and the Troponin Complex 
 TnC is similar to CaM in both structure and in function. Like CaM, TnC belongs to the EF-
hand superfamily of proteins and consists of two domains, N-terminal and C-terminal, connected 
by a flexible linker. Each of the two domains contains two EF-hand motifs that can coordinate and 
bind calcium ions (and magnesium ions). The C-terminal domain of TnC has a high affinity for 
both calcium and magnesium and is most often implicated in complexing TnC to the other troponin 
subunits – TnI and troponin T (TnT) (Davis & Tikunova, 2008; Jin, 2014). In the isoforms that are 
discussed in this thesis, the N-terminal domain of TnC the first EF-hand motif is unable to bind 




than the C-terminal domain (Tikunova & Davis, 2004). Similarly to CaM, this allows for the C-
terminal domain to act as an anchor and for the N-terminal domain to play the regulatory role.  
 This regulatory role allows for TnC to be a calcium-sensing switch to regulate contraction 
and relaxation in both cardiac and skeletal muscle. Once calcium binds the N-terminal domain of 
TnC, contraction is initiated. Through a series of conformational changes, the switch peptide 
region of TnI binds TnC, the inhibitory peptide region of TnI releases from actin and leads to 
repositioning of tropomyosin, leaving the myosin binding sites on actin exposed. The resulting 
interactions between actin and myosin produce the force that is seen during muscle contraction. 
After the stimulus ceases, the dissociation of calcium from TnC initiates the relaxation process. 
The inhibitory region of TnI once again binds actin, tropomyosin is again repositioned back to its 
inhibitory spot, and the actin-myosin interactions are blocked (Layland et al., 2005; Davis & 
Tikunova, 2008). Due to its role in the critical physiological process of muscle contraction and 
relaxation, the significance of TnC cannot be understated. Mutations in TnC, as well as the other 
proteins in the troponin complex, have been linked to cardiomyopathy (Liu et al., 2012a; Liu et 
al., 2012b; Li et al., 2013). Specifically, mutations that enhance apparent calcium affinity of 
troponin are linked to hypertrophic and restrictive cardiomyopathy (Davis et al., 2007a; Liu et al., 
2012b; Li et al., 2013; Alves et al., 2014), and mutations that decrease the apparent calcium 
sensitivity are implicated in dilated cardiomyopathy (Liu et al., 2012b). However, there are several 
different ways that apparent calcium sensitivity can be modified. As such, it is unlikely that each 
individual mechanism would lead to a disease state. For example, a calcium sensitized TnC mutant 
has been shown to improve contraction and cardiac function in mouse models of myocardial 




an important role in muscle physiology, and it is important to understand the mechanisms by which 
its calcium binding and structural dynamics within the troponin complex are regulated.  
 Interestingly, the calcium binding properties of TnC depend on its interactions with other 
troponin proteins as well as thin and thick filament proteins (Davis et al., 2007b), similar to CaM 
and its target proteins. The N-terminal domain of the isolated TnC protein has a relatively low 
calcium binding affinity and a fast rate of calcium dissociation (Tikunova & Davis, 2004). 
Complexing TnC with TnI and TnT increases the affinity for calcium and decreases the calcium 
dissociation rate (Davis et al., 2007b; Liu et al., 2012b). In reconstituted thin filaments containing 
S1 myosin, the calcium affinity is highest, and the calcium dissociation rate is slowest (Tikunova 
& Davis, 2004; Little, 2012). However, in reconstituted thin filaments alone, the calcium affinity 
is lower than the troponin complex and thin filaments with S1 myosin (although not as low as the 
isolated protein), and the calcium dissociation rate shows the same pattern. Given that TnI binding 
to TnC has a large effect on stabilization, it makes sense that the troponin complex and the thin 
filaments have higher calcium affinities than the isolated TnC protein. But the lower calcium 
affinity and higher calcium dissociation rate in the thin filament compared the troponin complex 
and the thin filament with S1 myosin needs further explanation. To do this, the idea of effective 
concentration can be introduced. Within the troponin complex, TnC “sees” TnI at a high frequency 
because the proteins do not dissociate and operate in a limited volume, in essence increasing their 
effective concentration so they are free to interact, increasing the stability of TnC and hence 
increasing the calcium affinity (Siddiqui et al., 2016). In the thin filament, there is competition for 
TnI from actin and tropomyosin, so the effective concentration of TnI is lower and TnC’s calcium 
affinity suffers as a result (Siddiqui et al., 2016). The addition of S1 myosin undoes much of the 




calcium affinity and calcium dissociation rates of TnC to levels similar to the troponin complex 
(Siddiqui et al., 2016; Davis et al., 2007b). 
 In addition to mutations in TnC, mutations and post-translational modifications of the other 
troponin proteins can modulate the behavior of muscle and/or cause it to enter a disease state. 
Mutations in TnI and TnT have been implicated in forms of dilated and restrictive/hypertrophic 
cardiomyopathy (Du et al., 2007; Liu et al., 2012a; Liu et al., 2012b; Li et al., 2013). Mutations in 
TnI and TnT as well as post-translational modifications such as phosphorylation have previously 
been characterized in terms of their effects on the calcium binding properties of TnC, both as part 
of the troponin complex and as part of the thin filament (Liu et al., 2012b; Liu et al., 2014). The 
general pattern seen is that mutations associated with dilated cardiomyopathy decrease the calcium 
affinity of TnC in thin filaments, and mutations associated with hypertrophic and restrictive 
cardiomyopathy increase the calcium affinity (Liu et al., 2012b). Phosphorylations can also 
influence the calcium affinity of TnC in thin filaments, either increasing or decreasing the affinity 
based on the location of the modification (Liu et al., 2014). Interestingly, while these mutations 
and post-translational modifications have effects on the thin filament calcium sensitivity, the 
majority of them do not change the calcium binding properties of the isolated troponin complex, 
potentially indicating that the mutations and modifications affect how the troponin complex 
interacts with actin and tropomyosin as opposed to affecting the troponin complex itself (Liu et 
al., 2012b; Liu et al., 2014). 
 It is important to note that the troponin complex, and hence the contractile apparatus as a 
whole, is not completely the same between different muscle types. Within the three muscle types 
that contain troponin – cardiac, slow skeletal, and fast skeletal (there is no troponin present in 




TnC, where cardiac and slow skeletal muscle share the same TnC isoform. Evidently, the calcium 
binding properties of the troponin complex and of the thin filament differ between muscle types. 
For example, the slow skeletal troponin complex is more sensitive to calcium than the cardiac 
troponin complex by ~3-fold, and the calcium dissociation rate for the slow skeletal troponin 
complex is slower by a similar magnitude (Davis et al., 2007b; Gomes et al., 2004). These 
differences are less dramatic when considering the reconstituted thin filament, but are still seen 
nonetheless (Davis et al., 2007b; Gomes et al., 2004). These comparisons are intriguing because 
the TnC isoform is unchanged between cardiac and slow skeletal muscle, so any differences in 
calcium binding properties must come from differences in the non-calcium binding proteins 
present in the troponin complex (TnI and/or TnT). It is likely that TnI differences exert stronger 
influences, given that TnI and TnC interact as part of the contractile process.  
Previous Troponin Models 
 In addition to mathematical models of CaM, this project is not the first to describe the 
calcium binding properties of the troponin complex using a mathematical model. The Davis lab 
has previously utilized this approach to describe the calcium binding properties of the troponin 
complex and the thin filament with the cardiac isoforms (Siddiqui et al., 2016). The model has 
four states: (1) TnC, (2) TnC-Ca2+, (3) TnC-Ca2+-TnI, and (4) TnC-TnI (Figure 1). The 
requirement for four states can be explained by building up from fewer states to more states. A 
two-state model with only TnC and TnC-Ca2+ can simulate the steady-state and kinetic properties 
of the troponin complex and the thin filament, but this model then must assume that the intrinsic 
calcium association and dissociation rates from TnC change in order to explain the observed 
differences between systems. This would implicate that within different systems the EF-hand in 




TnT changes, which is not as logical as changes in calcium binding properties being due to 
particular perturbations that do not include structural changes in calcium-bound TnC, such as the 
binding of TnI (Siddiqui et al., 2016). Thus, it is logical that a third state should be added in which 
TnC is bound to both calcium and TnI. With the addition of TnI to the model, the differences in 
calcium affinity and dissociation rate can be simulated with the same intrinsic rate parameters 
solely by altering the effective concentration of TnI (Siddiqui et al., 2016). However, the three-
state model predicts that as TnI effective concentration is increased, the affinity of the system for 
calcium approaches infinity (KD approaches 0) and the calcium dissociation rate asymptotes at 0, 
which is not the case based on biochemical studies (Siddiqui et al., 2016). Therefore, the fourth 
state is required, created when the TnC-Ca2+-TnI state dissociates by releasing calcium as opposed 
to TnI. With the four-state model, an infinite increase in TnI effective concentration leads to the 
calcium affinity and dissociation rate approaching the values that are measured for the troponin 
complex, in which a saturating effective concentration of TnI can be assumed (Siddiqui et al., 
2016). Thus, a four-state model is deemed to be accurate for describing the calcium binding 
properties of TnC within various systems.  
 However, since there are different isoforms of the troponin proteins in the different muscle 
types, this previous model is only valid for cardiac muscle since the experimental verification used 
was data from the cardiac isoforms. Of course, there is nothing wrong with centering attention at 
cardiac muscle – any defects in cardiac contractility will have severe effects on an individual. But 
there are also merits to studying other muscle types, both to aid in understanding disease states in 
noncardiac muscle and potentially using insights from noncardiac muscle to aid in the effort to 




the calcium binding properties of noncardiac muscle types would be useful. This is another goal 
of the current project.  
 In addition, a mathematical model for troponin can be useful to learn more about the effect 
of potential small molecule drugs on the system. As described earlier, changing the properties of 
troponin through mutation or post-translational modification can have a dramatic effect on the 
calcium binding properties of the system and hence the contractile properties, so it is logical to 
presume that a small molecule that can change the calcium binding properties of TnC has potential 
as a therapeutic. Using experimental data to obtain the affinity and kinetics of small molecule 
binding as well as which specific state binding occurs in, the small molecule can be incorporated 
into the mathematical model and the details of its binding and/or potential implications of further 
tweaking of the system can be investigated. In essence, a previously built troponin model is 
effective at simulating the calcium binding properties of TnC in different systems, but this project 
aims to expand that model to different troponin isoforms and to incorporate a potential small 
molecule therapeutic into the model. 
Chapter 2 - Methods 
Although this thesis will discuss experiments performed with multiple CaM variants as 
well as various troponin protein isoforms, a significant portion of the experimental (wet lab) data 
collected with these proteins comes from work performed before the onset of this thesis and by 
researchers other than the author, so for the sake of brevity only the most relevant wet lab 






Protein Expression & Purification  
 Mammalian wild type CaM, sCaM1, sCaM4, and TnC DNA constructs in the pET17b 
vector were expressed in BL21 DE3 Escherichia coli in LB medium, with DNA expression aided 
by the presence of IPTG to activate the promoter. The DNA construct for the engineered CaM as 
well as the constructs for CaMF19W, sCaM1F19W, sCaM4F19W, TnCF27W, and TnCT53C were 
generated from their respective wild type plasmids. Primer-selected site-directed mutagenesis was 
performed using a QuikChange Lightning Multi-site kit from Agilent following the manufacturer’s 
PCR protocol. Following PCR, the identities of the engineered CaM, the CaM mutants, and the 
TnC mutants were confirmed by DNA sequence analysis (GeneWiz), and subsequently expressed 
in the same manner as the other proteins. Following DNA expression in the bacteria, the various 
proteins were purified using standard laboratory procedures including sonication, centrifugation, 
precipitation, and column chromatography.   
Steady-State Calcium Titrations 
 To measure the steady-state calcium affinity of the different CaM variants, steady-state 
calcium titrations were performed. All steady-state fluorescence measurements were performed 
using a Perkin-Elmer LS 55 spectrofluorometer at 20 ℃, with the temperature maintained by a 
circulating water bath. The titration buffer consisted of 200 mM 3-(N-morpholino)propanesulfonic 
acid (MOPS), 150 mM KCl, and 2 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-
tetraacetic acid (EGTA, a calcium chelator) at pH 7.0. To follow the calcium dependent change in 
the C-terminal domain of CaM, Tyr fluorescence was excited at 275nm and monitored at 305nm 
as microliter amounts of CaCl2 were added to 2 ml of each CaM (1 µM) in titration buffer with 




(Robertson & Potter, 1984). To follow the calcium dependent change in the N-terminal domain of 
CaM, there are two methods, both of which were used. The first option is to mutate the very faintly 
fluorescent Phe19 residue in CaM (and both soybean CaMs) to a more prominently fluorescent 
Trp residue. In this case, Trp fluorescence was excited at 295nm and monitored at 350nm as 
microliter amounts of CaCl2 were added to the reaction mixture as previously described.  The 
second option is to use an extrinsic dye such as the fluorescent hydrophobic dye 4,4’-dianilino-
1,1’-binaphthyl-5,5’-disulfonic acid (bis-ANS) to monitor the change, as the dye fluoresces in a 
hydrophobic environment, such as when the N-terminal domain binds calcium to expose its 
hydrophobic core. In this case, bis-ANS fluorescence was excited at 390nm and monitored at 
500nm as microliter amounts of CaCl2 were added to the reaction mixture as previously described. 
The steady-state calcium affinity of TnC within different systems was measured with a 
similar procedure (Siddiqui et al., 2016). When monitoring calcium dependent conformational 
changes in TnC, only the N-terminal domain must be considered. Similar to the CaMs, this domain 
has no intrinsically fluorescent amino acids other than a faintly fluorescent Phe residue at position 
27. Thus, to follow the calcium dependent change in TnC (in any system), Phe27 was mutated to 
a more prominently fluorescent Trp residue, and the steady-state calcium titrations were performed 
as described above, except at 15 ℃. Each reported experimentally determined KD represents an 
average of at least three successive titrations ± standard error and fit with the Hill equation.  
Kinetic Experiments 
 All kinetic data for CaM were collected using an Applied Photophysics Ltd. Model SX.20 
MV stopped-flow instrument with a dead time of 1.4 ms at 20 ℃. Kinetic data for troponin systems 
were collected using an Applied Photophysics Ltd. Model SX.20 stopped-flow instrument with a 




MOPS and 150 mM KCl at pH 7.0. When necessary, Tyr fluorescence (used to follow calcium 
dependent changes in the C-terminal domain of CaM) was excited at 295nm and monitored using 
a UV-transmitting black glass (UG1) filter from Oriel, Trp fluorescence (used to follow calcium 
dependent changes in the N-terminal domain of CaM) was excited at 295nm and monitored using 
the same UG1 filter, bis-ANS fluorescence (used to follow the calcium dependent changes in the 
N-terminal domain of CaM as well) was excited at 390nm and monitored using a 500nm long pass 
interference filter from Newport (Walton et al., 2017). To follow calcium dependent changes in 
TnC in various systems, instead of using the TnCF27W protein, a different approach was taken. A 
T53C mutation was introduced, and the new Cys residue was subsequently labelled with 2-(4′- 
(iodoacetamido)anilino)naphthalene-6-sulfonic acid (IAANS), an environmentally sensitive 
fluorophore with a good signal-to-noise ratio. IAANS fluorescence was excited at 330nm and 
monitored using a 420-470nm band pass interference filter from Oriel (Siddiqui et al., 2016). 
 The first set of kinetic experiments are calcium dissociation experiments. To measure the 
calcium dissociation rate from the C-terminal domain of CaM, stopped-flow buffer with 200 µM 
calcium and 3 µM CaM was rapidly mixed with 10 mM EGTA in stopped-flow buffer (Walton et 
al., 2017). To measure the calcium dissociation rate from the N-terminal domain of CaM, stopped-
flow buffer with 200 µM calcium and 1 µM CaMF19W (or 1 µM CaM and 0.5 µM bis-ANS) was 
rapidly mixed with 10 mM EGTA in stopped-flow buffer (Walton et al., 2017). These experiments 
were performed with all CaM variants. Calcium dissociation rates from TnC were measured in a 
similar fashion (Siddiqui et al., 2016). As an example, for isolated TnC, stopped-flow buffer with 
saturating calcium and 1 µM T53C-IAANS TnC was rapidly mixed with 10 mM EGTA in stopped-




 Next, there are calcium association experiments. While these do not measure intrinsic 
calcium association rates (which are usually in the range of 106 – 109 M-1s-1), they do give apparent 
rates (usually ~300/s or less) that change with varying initial calcium concentrations. To measure 
the calcium association rate to the C-terminal domain of CaM, stopped-flow buffer with 3 µM 
CaM and 15 µM EGTA was rapidly mixed with increasing concentrations of calcium (2.5, 5, 10, 
20, and 40 µM) in stopped-flow buffer. There were no experiments performed to measure the 
calcium association rate to the N-terminal domain of CaM, and the experiments described with the 
C-terminal domain were only performed with mammalian CaM and the engineered CaM. There 
were no experiments performed to measure the calcium association rate to TnC.  
 Finally, there are transient occupancy (TO) experiments. These indirectly measure calcium 
association rates by creating artificial calcium transients and monitoring the level of calcium 
saturation of CaM and TnC over time. To measure the TO of the N-terminal domain of CaM, 
stopped-flow buffer with 2 µM CaMF19W and 2 mM EGTA was rapidly mixed with either 100 or 
250 µM calcium in stopped-flow buffer (Walton et al., 2017). TOs were only performed with the 
two soybean CaMs, and there were no TO experiments performed following the C-terminal 
domain. There were no TO experiments performed to following TnC in any system that ended up 
being relevant to this project. 
Model Creation & Simulations 
 All mathematical models were built and all simulations performed using the Copasi® 
software (Version 4.24). This software program is a standard biochemical modeling program 
which is user-friendly and very powerful. The program performs simulations by solving 




kinetic parameters, and the concentration of each species at a given time point. For CaM models, 
the differential equations necessary are:  
𝑑[𝐶𝑎]
𝑑𝑡
= 𝑘 , [𝐶𝑎 𝐶𝑎𝑀] + 𝑘 , [𝐶𝑎 𝐶𝑎𝑀] + 𝑘 , [𝐶𝑎 · 𝐸𝐺𝑇𝐴] − 𝑘 , [𝐶𝑎][𝐶𝑎𝑀]
− 𝑘 , [𝐶𝑎][𝐶𝑎 𝐶𝑎𝑀] − 𝑘 , [𝐶𝑎][𝐸𝐺𝑇𝐴]  
𝑑[𝐶𝑎𝑀]
𝑑𝑡
= 𝑘 , [𝐶𝑎 𝐶𝑎𝑀] − 𝑘 , [𝐶𝑎][𝐶𝑎𝑀] 
𝑑[𝐶𝑎 𝐶𝑎𝑀]
𝑑𝑡
= 𝑘 , [𝐶𝑎][𝐶𝑎𝑀] + 𝑘 , [𝐶𝑎 𝐶𝑎𝑀] − 𝑘 , [𝐶𝑎 𝐶𝑎𝑀] − 𝑘 , [𝐶𝑎][𝐶𝑎 𝐶𝑎𝑀] 
𝑑[𝐶𝑎 𝐶𝑎𝑀]
𝑑𝑡
= 𝑘 , [𝐶𝑎][𝐶𝑎 𝐶𝑎𝑀] − 𝑘 , [𝐶𝑎 𝐶𝑎𝑀] 
𝑑[𝐸𝐺𝑇𝐴]
𝑑𝑡
= 𝑘 , [𝐶𝑎 · 𝐸𝐺𝑇𝐴] − 𝑘 , [𝐶𝑎][𝐸𝐺𝑇𝐴] 
𝑑[𝐶𝑎 · 𝐸𝐺𝑇𝐴]
𝑑𝑡
= 𝑘 , [𝐶𝑎][𝐸𝐺𝑇𝐴] − 𝑘 , [𝐶𝑎 · 𝐸𝐺𝑇𝐴] 
where CaM is an apo domain of CaM (either N-terminal or C-terminal), Ca1CaM is a CaM domain 
with one calcium ion bound, Ca2CaM is a CaM domain with two calcium ions bound, and 
Ca·EGTA is calcium chelated by EGTA. Rate parameters with a subscript “1” describe the kinetic 
parameters of the binding of the first calcium ion to an apo CaM domain, rate parameters with a 
subscript “2” describe the kinetic parameters of the binding of the second calcium ion to Ca1CaM, 
and rate parameters with a subscript “EGTA” describe the kinetic parameters of the chelating of 
calcium by EGTA. For troponin models, the differential equations necessary are: 
𝑑[𝐶𝑎]
𝑑𝑡
= 𝑘 , [𝑇𝑛𝐶 · 𝐶𝑎] + 𝑘 , [𝑇𝑛𝐶 · 𝐶𝑎 · 𝑇𝑛𝐼] + 𝑘 , [𝐶𝑎 · 𝐸𝐺𝑇𝐴] − 𝑘 , [𝐶𝑎][𝑇𝑛𝐶]






= 𝑘 , [𝑇𝑛𝐶 · 𝐶𝑎] + 𝑘 , [𝑇𝑛𝐶 · 𝑇𝑛𝐼] − 𝑘 , [𝐶𝑎][𝑇𝑛𝐶] 
𝑑[𝑇𝑛𝐶 · 𝐶𝑎]
𝑑𝑡
= 𝑘 , [𝐶𝑎][𝑇𝑛𝐶] + 𝑘 , [𝑇𝑛𝐶 · 𝐶𝑎 · 𝑇𝑛𝐼] − 𝑘 , [𝑇𝑛𝐶 · 𝐶𝑎] − 𝑘 , [𝑇𝑛𝐶
· 𝐶𝑎][𝑇𝑛𝐼] 
𝑑[𝑇𝑛𝐶 · 𝐶𝑎 · 𝑇𝑛𝐼]
𝑑𝑡
= 𝑘 , [𝑇𝑛𝐶 · 𝐶𝑎][𝑇𝑛𝐼] + 𝑘 , [𝐶𝑎][𝑇𝑛𝐶 · 𝑇𝑛𝐼] − 𝑘 , [𝑇𝑛𝐶 · 𝐶𝑎 · 𝑇𝑛𝐼] − 
                            𝑘 , [𝑇𝑛𝐶 · 𝐶𝑎 · 𝑇𝑛𝐼] 
𝑑[𝑇𝑛𝐶 · 𝑇𝑛𝐼]
𝑑𝑡
= 𝑘 , [𝑇𝑛𝐶 · 𝐶𝑎 · 𝑇𝑛𝐼] − 𝑘 , [𝐶𝑎][𝑇𝑛𝐶 · 𝑇𝑛𝐼] − 𝑘 , [𝑇𝑛𝐶 · 𝑇𝑛𝐼] 
𝑑[𝐸𝐺𝑇𝐴]
𝑑𝑡
= 𝑘 , [𝐶𝑎 · 𝐸𝐺𝑇𝐴] − 𝑘 , [𝐶𝑎][𝐸𝐺𝑇𝐴] 
𝑑[𝐶𝑎 · 𝐸𝐺𝑇𝐴]
𝑑𝑡
= 𝑘 , [𝐶𝑎][𝐸𝐺𝑇𝐴] − 𝑘 , [𝐶𝑎 · 𝐸𝐺𝑇𝐴] 
where TnC is apo TnC, TnC·Ca is TnC bound to calcium, TnC·Ca·TnI is TnC bound to both 
calcium and TnI, TnC·TnI is TnC bound to TnI, and Ca·EGTA is calcium chelated by EGTA. Rate 
parameters with a subscript “1” describe the kinetic parameters of the binding of calcium to TnC, 
rate parameters with a subscript “2” describe the kinetic parameters of the binding of TnI to TnC-
Ca2+, rate parameters with a subscript “3” describe the kinetic parameters of the binding of calcium 
to TnC-TnI, rate parameters with a subscript “4” describe the kinetic parameters of the dissociation 
of TnC-TnI into its constitutive proteins, and rate parameters with a subscript “EGTA” describe 
the kinetic parameters of the chelating of calcium by EGTA.  
 Copasi® has multiple different functions that can be used to accomplish multiple different 




will be, given starting concentrations inputted by the user. The “time course” task is used to 
calculate the transient concentrations of all species will be over a given period of time, given 
starting concentrations inputted by the user. Within this task, both the length of the simulation and 
the number of intervals can be specified by the user. Importantly, the user can opt to have the 
concentration of a species remain fixed throughout a steady-state or time course simulation as 
opposed to letting the species change in concentration based on the reaction mixture. This option 
allows for useful flexibility within simulations. Finally, the “optimization” task is used to calculate 
an ideal (or optimal) starting concentration for a species or rate parameter to match a given output 
or simulation result desired by the user. The program runs a large number of simulations (specified 
by the user, usually anywhere ranging from 100,000 to 1,000,000) and varies the specified 
parameter between given bounds to find the optimal value of the parameter. 
 To simulate steady-state calcium binding curves with CaM, the “steady-state” task was 
used. The inputted starting concentrations were 0.5 µM CaM and the calcium concentration was 
fixed at different values ranging from 1 pM to 316 µM (pCa 9–3.5), and for each calcium 
concentration the equilibrium concentration of Ca2CaM was plotted. For troponin models, no 
steady-state binding curves were simulated, only verification of KD was required. To do this, the 
“steady-state” task was used, with inputted started concentrations of 1 µM TnC and either 1.22 
mM or 12.3 µM TnI (depending on whether the system was the troponin complex or the thin 
filament, respectively), and the calcium concentration was fixed at the KD value. To verify the KD, 
the “steady-state” task was run and the equilibrium concentration of TnC-Ca2+-TnI was verified to 
be ~ 0.5 µM.  
 To simulate calcium dissociation curves with CaM, the “time course” task was used. The 




µM. The time course simulation was run for 0.4 s, with an interval length of 1 µs, and a plot was 
created showing the concentration of Ca2CaM over time. To calculate the calcium dissociation 
rate, the following equation was used, since the calcium dissociation curve is a single exponential: 




where t1/2 is the time point at which the Ca2CaM concentration is half of its original value (in this 
case, 0.5 µM). The same “time course” task was used to simulate calcium dissociation curves from 
troponin. The inputted starting concentrations were 1 µM TnC-Ca2+-TnI and either 1.22 mM or 
12.3 µM TnI (depending on whether the system was the troponin complex or the thin filament, 
respectively), and the calcium concentration was fixed at 0 µM. The time course simulation was 
run for 0.2 s, with an interval length of 1 µs. To calculate the calcium dissociation rate, the same 
equation was used, with the exception that t1/2 in this case is the time point at which the TnC-Ca2+-
TnI concentration is half its original value (in this case, 0.5 µM). 
 To simulate calcium association curves with CaM, the “time course” task was also used. 
The inputted starting concentrations were 3 µM CaM, 6 µM EGTA (but with kinetics that match 
the other domain that was not being simulated), and either 2.5, 5, 10, 20, or 40 µM calcium. The 
time course simulation was run for 0.4 s, with an interval length of 1 µs, and a plot was created 
showing the concentration of Ca2CaM over time. To calculate the calcium association rate, the 
following equation was used: 




where t1/2 is the time point at which the Ca2CaM concentration is half of its maximum value (which 




 To simulate transient occupancy curves with CaM, the “time course” task was used. The 
inputted starting concentrations were 1 µM CaM, 1 mM EGTA (with regular EGTA kinetics), and 
either 50 or 125 µM calcium. The time course simulation was run for 0.1 s, with an interval length 
of 1 µs, and a plot was created showing the concentration of Ca2CaM over time. The transient 
occupancy was calculated by dividing the concentration of Ca2CaM at 1.5 ms (close to the peak) 
by the total concentration of CaM (1 µM). The same “time course” task was used to simulate 
transient occupancy curves with troponin. The inputted starting concentrations were 1 µM TnC, 
either 1.22 mM or 12.3 µM TnI (depending on whether the system was the troponin complex or 
the thin filament, respectively), 500 µM EGTA (with regular EGTA kinetics), and 50 µM calcium. 
The time course simulation was run for 0.1 s, with an interval length of 1 µs, and a plot was created 
showing the concentration of TnC-Ca2+-TnI over time. The transient occupancy was calculated by 
dividing the concentration of TnC-Ca2+-TnI at 3.5 ms (close to the peak) by the total concentration 
of TnC (1 µM).  
Chapter 3 – Results 
 The first step to creating a model for calcium binding to CaM is to determine the individual 
steps that should be included. There are essentially two options to choose from when considering 
only one domain of CaM (so, two calcium ions): the first is what can be called a series model, in 
which the first step is calcium binding to apo CaM and the second step is calcium binding to 
Ca1CaM, and the second is a parallel model in which the first calcium ion that binds has the option 
to bind to site 1 or site 2 on CaM, creating two branches and two potential pathways for complete 
CaM activation (Figure 2). For the sake of simplicity, the series model was chosen to simulate the 
calcium binding properties of wild type and other CaMs, although attempts to model the system 




Wild Type Calmodulin – C Domain 
 The first model to be built, and the one on which the most time was spent, was the 
mathematical model for calcium binding to the C-terminal domain of mammalian CaM (also 
referred to as wild-type or wt CaM). Given the experimental steady-state and kinetic data, the rate 
parameters for each step of the reaction were determined that accurately simulated both a steady-
state calcium titration and various kinetic curves (see Figure 3). The parameters have several 
important features and relationships that are necessary to point out. Primarily, the cooperativity 
that is seen within the binding of the two calcium ions is reflected in the model. Before plugging 
in parameters, the structure of the model itself introduces cooperativity simply with the fact that 
each calcium ion has its own step – if each step had identical rate parameters, a simulate titration 
curve would still have a steepness to it indicative of cooperativity. In order to add to and effectively 
simulate the cooperativity, kon,2 is faster than kon,1, and koff,1 is faster than koff,2. Second, the 
experimentally observed calcium dissociation rate is the value of koff,2, indicating that koff,1 has no 
effect on the calcium dissociation rate and will only influence the overall KD of the system. 
Similarly, the parameter which has the greatest effect on the calcium association rate of the system 
is kon,1, hence kon,2 only has a significant influence on the overall KD of the system.  
Other Calmodulin Variants – C Domain 
 As discussed previously, different variants of CaM have different calcium binding 
properties. Therefore, a different model must be created for each CaM variant. However, a new 
model can be built that accurately describes the calcium binding properties of other CaMs without 
changing the structure of the model, and by only changing the kinetic parameters. As such, a model 
with rate parameters that accurately simulate the calcium affinity and kinetic properties of the C-




model to the wild type model allows for several interesting insights. Firstly, since the engineered 
CaM has a calcium dissociation rate ~4-fold slower than wild type CaM, the rate parameter koff,2 
is also ~4-fold lower than the koff,2 of the wild type CaM. Second, it is worth noting that although 
this decrease in koff,2 would increase the calcium affinity of the engineered CaM, it would not do 
so to the same magnitude as is seen in the experimental data (almost an order of magnitude). 
Hence, kon,1 must increase and koff,1 must decrease, compared to wild type CaM, to allow for the 
engineered CaM model to accurately simulate the experimental data. Notably, the change in koff,1 
is more dramatic than the change in kon,1. kon,1 has a less dramatic change because, as mentioned 
previously, it is the major parameter that influences calcium association rates, for which there is 
not a large difference between wild type CaM and the engineered CaM. 
 In addition to the engineered CaM, models can be built for the C-terminal domain of both 
soybean CaMs, again using the same basic structure of the model and only changing the rate 
parameters. A model with rate parameters that accurately simulate the calcium affinity and the 
calcium dissociation rate of sCaM1 was created (Figure 5). sCaM1 has a calcium affinity slightly 
higher than that of wild type CaM, but a calcium dissociation rate that is ~4-fold faster. Thus, the 
decrease in affinity caused by an increased in koff,2 had to be counteracted by decreasing koff,1 and 
increasing both kon,1 and kon,2 to match the experimental KD. A model was also created with rate 
parameters that accurately simulate the calcium affinity and the calcium dissociation rate of sCaM4 
(Figure 6). sCaM4 has a calcium affinity ~3-fold higher than wild type CaM, and a similar calcium 
dissociation rate. Thus, the main changes in the rate parameters were a decrease in koff,1 and 
increases in both kon,1 and kon,2, similar to sCaM1. It is important to note that for both of the soybean 
CaM C-terminal domain models, there was no available experimental data for calcium association 




models (given only calcium affinity and dissociation rate to match), and it is possible that these 
rate parameters would not accurately simulate calcium associate rate or transient occupancy 
experiments. 
Finally, models can be built for the C-terminal domain of mammalian CaM mutants that 
are associated with disease, again using the same basic structure of the model and only changing 
the rate parameters. A model with rate parameters that accurately simulate the calcium affinity and 
calcium dissociation rate of N54I CaM was created (Figure 7). N54I CaM has a calcium affinity 
slightly lower than wild type CaM, and a calcium dissociation rate that is slightly slower than wild 
type CaM. Since a decrease in koff,2 increases the calcium affinity, a concurrent increase in koff,1 
was introduced to accurately simulate the experimentally determined affinity. A model with rate 
parameters that accurately simulate the calcium affinity and calcium dissociation rate of N98S 
CaM was also created (Figure 8). This model is more interesting than some of the others. When 
the same basic structure of the model is used, the simulated calcium titration curve is steeper than 
the experimental curve, indicative of excess cooperativity. Thus, the basic structure of the model 
must be changed, since simply changing the rate parameters to deplete the cooperativity (i.e., make 
kon,1 ≈ kon,2 and koff,1 ≈ koff,2) does not flatten the curve enough. When the basic structure is changed 
so that there is only one calcium ion binding to CaM, the steepness of the simulated titration curve 
matches the experimental curve. Here a modeling approach allows the conclusion to be reached 
that the N98S mutation hinders or abolishes calcium binding at one of the two binding sites in the 
C-terminal domain, a conclusion which can be further supported by noting that the 98 th residue of 
CaM is part of the loop of one of the helix-loop-helix calcium binding motifs. The relationship 
between the experimental data and the rate parameters in the one-calcium model is more direct – 




kon can be calculated from the KD using the formula KD = koff/kon. While there is no experimental 
data for calcium association rates, if the one-calcium model is correct, the simulated calcium 
association rates should match any experimentally determined rates.  
Wild Type and Other Calmodulin Variants – N Domain 
 Since these mathematical models only simulate individual domains of CaM, it is necessary 
to create a different model for the calcium binding properties of the N-terminal domain as well. 
The N-terminal domain shares the same general properties as the C-terminal domain, specifically, 
it binds two calcium ions as well and exhibits a similar level of cooperativity, so the same basic 
structure of the model can be used. Using this basic structure, a model with rate parameters that 
accurately simulate the calcium affinity and calcium dissociation rate of the N-terminal domain of 
wild-type CaM was created (Figure 9). Comparing this to the C-terminal domain, the calcium 
dissociation rate of the N-terminal domain is almost two orders of magnitude faster than the C-
terminal domain, but the affinity is only ~2-fold lower. Thus, the high koff,1 and koff,2 values of the 
N-terminal domain are complemented with faster kon,1 and kon,2 values, with kon,2 approaching the 
diffusion-controlled limit for a rate constant. That being said, there is no experimental data for 
calcium association rates, so the rate parameters presented here are only one of a large set of 
possible solutions to these models, and it is possible that these rate parameters would not accurately 
simulate calcium associate rate or transient occupancy experiments. To put a positive spin on this, 
simulations with this model can be used to predict experimental data, which has its own merits. 
 The same basic model structure can of course also be applied to the N-terminal domain of 
the different CaM variants. A model with rate parameters that accurately simulate the calcium 
binding properties of the N-terminal domain of sCaM1 was created (Figure 10). The calcium 




CaM, and the affinity is only slightly higher than that of wild-type CaM. Due to the difference in 
calcium dissociation rate, koff,2 is slightly higher for sCaM1, and interestingly, to accurately 
simulate the experimental calcium association data, kon,1 must be slower than wild type. Both of 
these changes would decrease the affinity compared to wild type. So, to compensate for this and 
increases the affinity, koff,1 is much slower than wild type, and is even slower than koff,2 in this 
model, which is not consistent with the principles of cooperativity that must be incorporated into 
the model. However, it is important to note that there is calcium association rate data for the N-
terminal domain of sCaM1, so there is higher confidence in the value for kon,1 and kon,2.  
 Finally, a model with rate parameters that effectively simulate the calcium binding 
properties of the N-terminal domain of sCaM4 was created (Figure 11). The calcium dissociation 
rate of sCaM4 is ~2-fold slower than wild-type CaM, and the calcium affinity is ~2.5-fold higher. 
Similar to sCaM1, the most interesting aspect of this model is the calcium association rates. In 
order to simulate these data, kon,1 must be slower than kon,1 for wild type, so koff,1 must decrease to 
maintain the correct calcium affinity in the model. This leads to koff,1 being slower to koff,2, which 
again is not consistent with the principles of cooperativity that must be incorporated into the model. 
However, the presented parameters only accurately simulate half of the experimental data for 
calcium association. Given the presented basic structure of the model, there is no set of rate 
parameters that can accurately simulate all of the calcium association data. Perhaps a mathematical 
model for the N-terminal domain of sCaM4 requires additional complexity to accurately simulate 
all experimental data. 
Symmetrical Parallel Model of Wild Type C Domain 
 As mentioned previously, the series model of calcium binding was chosen to simulate the 




it is actually possible to obtain a single solution to a model given a complete set of experimental 
data. However, creating parallel models that can accurately simulate the calcium binding data of 
CaM can be interesting as a thought experiment at the very least. There are two approaches to 
building a parallel model: it can be assumed that the two branches are symmetrical, meaning they 
have identical rate parameters, or the two branches can be asymmetrical, meaning they have 
different rate parameters. A symmetrical model is slightly simpler, so this approach was used first. 
The set of rate parameters within the parallel structure that create a symmetrical model that 
accurately simulates the calcium binding properties of the C-terminal domain of wild-type CaM 
are presented in Figure 12. As expected, the individual rate parameters are slower than their 
“corresponding” rate parameters in the series model, since there are two paths for complete 
calcium binding. But of course, a symmetrical model with this parameter set is not the only solution 
to the parallel model structure that can accurately simulate the calcium binding properties of CaM. 
Asymmetrical Parallel Models of Wild Type C Domain 
Since there are more parameters in the parameter set for a parallel model, there is a large 
number of solutions to the model given a complete array of experimental data. In addition to the 
symmetrical model described above, the model can be asymmetrical, and in a practically infinite 
number of ways. Two examples of sets of rate parameters within the parallel structure that create 
an asymmetrical model that accurately simulates the calcium binding properties of the C-terminal 
domain of wild-type CaM are presented in Figure 13. The first is “less” asymmetrical, with the 
affinity of the binding of the first calcium to site one approximately 1.5 times higher than the 
affinity for site 2. The second example is “more” asymmetrical, with the affinity of binding to site 
one approximately 45 times higher than the affinity for site 2. These two examples are only two 




accurately simulate all of the available experimental data. There are currently no known 
experiments that would allow for further characterization of the individual reactions seen in the 
parallel structure, so only a sample of potential solutions can be provided. 
Slow Skeletal Troponin Model 
 As mentioned previously, a mathematical model of the activation of cardiac troponin has 
been created by a former graduate student in the Davis lab. This model works well for the cardiac 
isoforms of the troponin proteins, but it is important to understand the kinetics of the activation of 
troponin in other muscle types. Skeletal muscle disease is widely prevalent, and thus describing 
the calcium binding properties of skeletal muscle troponin is useful. For this project, slow skeletal 
troponin isoforms were chosen over the fast skeletal isoforms because in the long run, focusing on 
slow skeletal muscle fibers has more promise than focusing on fast skeletal muscle fibers. The 
different isoforms between these two muscle types lead to differences in their calcium binding 
properties – slow skeletal troponin has a higher calcium affinity when considering both the isolated 
troponin complex (~3-fold higher) and the thin filament (~1.2-fold higher) and slow skeletal 
troponin has a slower calcium dissociation rate when considering both the isolated troponin 
complex (~5-fold slower) and the thin filament (~1.3-fold slower). Given the relative complexity 
of the model, it was important to narrow down which parameters were candidates for manipulation. 
Since the TnC isoform is the same in cardiac and slow skeletal muscle, any rate parameters 
describing the kinetics of calcium binding to TnC were assumed to remain the same, as well as the 
dissociation of the TnC-TnI state back into its individual components. Thus, only kon,2 and koff,2 





 The first step was to decrease koff,3, since the koff,3 value for the cardiac model was too high 
to work with the slow calcium dissociation rate of slow skeletal troponin. Next was to manipulate 
both kon,2 and koff,2 in the troponin complex to match the KD and the calcium dissociation rate of 
the isolated slow skeletal troponin complex, maintaining the effective concentration of TnI at the 
same value as it was for the cardiac troponin complex, since it is assumed that the troponin complex 
has saturating TnI. Since there is no experimental data for calcium association rate, there were 
multiple sets of rate parameters that would match the other experimental data (however, not an 
infinite number). The number of viable sets was cut down to two options: (1) kon,2 = 2.955 x 107 
M-1 s-1 and koff,2 = 110 s-1, since koff,2 = 110 s-1 in the cardiac model and koff,4 = 110 s-1; and (2) kon,2 
= 2.313 x 107 M-1 s-1 and koff,2 = 85 s-1, since the calcium dissociation rate for the slow skeletal thin 
filament is 85 s-1, and the same logic was used when determining koff,2 for the cardiac model (i.e.. 
koff,2 is equal to the calcium dissociation rate for the thin filament). These two options were 
translated to the thin filament, where an extra parameter played a role in determining calcium 
affinity and dissociation rate: the effective concentration of TnI. Using the same two sets of kon,2 
and koff,2, an effective concentration of TnI was calculated for each set that would accurately 
simulate the calcium affinity and dissociation rate. Thus, there are essentially two viable models 
that can describe the calcium binding properties of slow skeletal troponin (Table 1).   
 As anticipated, calcium association data is needed to further determine which of the two 
models is accurate. Interestingly, if the two models are used to simulate transient occupancy in the 
thin filament system, they give two significantly different values, one of which is much closer to 
the expected/simulated transient occupancy of the cardiac thin filament system (Figure 14). 




would be sufficient to identify which of the two potential models describes the calcium binding 
properties more accurately.  
Cardiac Troponin Drug Model 
 In addition to translating the previously made cardiac model into a slow skeletal model, it 
can be extended to include reactions and species that correspond to a small molecule drug binding 
to the closed state of TnC-Ca (Figure 15). A drug model can be useful to evaluate potential small 
molecule therapeutics and determine whether certain theories about the small molecule binding 
events are viable. In this case, the model was used to evaluate a single small molecule and its 
effects on the calcium binding properties of troponin. The small molecule was selected for 
evaluation based on computational models and high throughput screening of databases, and its 
interactions with troponin had previously been characterized through biochemical and structural 
(NMR) studies. To accurately describe its interactions, a clarification must be added to the model. 
The state TnC-Ca2+ in the original troponin model is a simplification – this state exists in either a 
“closed” or an “open” state, with an exchange rate of 30000 per second, and the closed state is 5% 
of the population in saturating calcium conditions (Cai et al., 2016). Returning to the small 
molecule’s interactions, based on the NMR studies, it can bind troponin in two states: (1) TnC-
Ca2+-Closed and (2) TnC-Ca2+-TnI (Cai et al., 2016). It is because of this second interaction that 
it was chosen for further studies, binding and subsequently stabilizing the active form of troponin 
should theoretically increase the calcium sensitivity of troponin, which is what is desired for a 
potential therapeutic. The small molecule binds the TnC-Ca2+-Closed state with an exchange rate 
of 1000 per second and a dissociation rate of 0.3 per second, giving an assumed KD of 300 µM, 
and it binds the TnC-Ca2+-TnI state with a koff of 1000 per second and a KD of 12 µM, giving an 




state, calcium dissociates at a rate of 10 per second, and it was assumed that the TnC-TnI-Drug 
state falls apart quickly at the same rate as TnC-TnI, 110 per second.  
 Once the small molecule had been added to the model, several different simulations were 
performed to try and validate experimental data and hypotheses of how the small molecule 
conferred its effects. There were a couple important takeaways from these simulations. Primarily, 
it was determined that in addition to sensitizing the thin filament to calcium, addition of the small 
molecule increased the maximum activation of troponin at saturating calcium conditions (Figure 
16). In the thin filament, where this effect is more pronounced, the effective concentration of TnI 
is only ~10-fold higher than the KD of the TnI binding reaction ([TnI]eff = 12.3 µM, KD,2 = 1.22 
µM). Thus, without the small molecule, at saturating calcium conditions only ~80-90% of troponin 
is fully activated. When the small molecule is added, it shifts the equilibrium towards the TnC-
Ca2+-TnI state and increases the maximum activation of the thin filament (i.e., the percentage of 
troponin that is fully active at saturating calcium). In addition to examining the sensitizing effects 
of the small molecule, it was important to look at the inhibitory effects as well, since it binds the 
closed state of TnC-Ca2+. It was hypothesized that the small molecule would have a significant 
inhibitory effect but based on the parameters assumed in the mathematical model, this was not the 
case. The population of troponin that ends up in the deactivated state in equilibrium is practically 
insignificant with the given parameters (Figure 17), and the affinity of the inhibitory reaction 
(small molecule binding the TnC-Ca2+-Closed state) has to increase significantly to give a relevant 







Chapter 4 - Discussion 
 As demonstrated, mathematical modeling has several merits and can be incredibly useful 
to describe and gain information about given biochemical systems. In this project, the biochemical 
systems modeled were two calcium binding protein systems – the two individual domains of 
calmodulin, and different isoforms and applications of the proteins in the troponin complex. For 
the different CaM variants, some models have been experimentally verified with a complete set of 
calcium binding data (i.e., steady state affinity, dissociation rate, and association rate), and some 
are lacking one set of data to verify the accuracy of the model. While it may seem that unverified 
models may not be useful, there are some new avenues that open up. These models can be used to 
predict experiments, which can either verify the model completely or indicate the need for change, 
much like the situation with the slow skeletal troponin model. Even then, with completely verified 
models, there is still predictive value. For example, a potential experiment may be tested and 
simulated with the model prior to physically performing it to see if there is merit to running the 
experiment in the first place. Returning to the slow skeletal example, a thin filament transient 
occupancy experiment was not the only one considered to potentially distinguish between the two 
models, so the models were used to determine that it was the only viable option as opposed to 
running experiments that would end up yielding no new results.  
It is this concept of predictive value that can be seen as the most useful aspect of models. 
In addition to considering what experiments to do in the future, the models can be used to design 
new experiments to answer new questions that may be too difficult to theorize about. In addition 
to noting how these models can simulate these calcium binding protein systems and aid in future 
experiments, it is also interesting to consider some of the different potential structures of the CaM 




Series vs. Parallel Models 
 As mentioned previously, there were two options to consider in terms of a structure for the 
model of calcium binding to CaM. Between the series and the parallel model, the series model was 
chosen as it was simpler with fewer parameters. However, if the point of the model is to represent 
calcium binding to individual domains as accurately as possible, a parallel model would be the 
better option. In essence, a series model is simply a parallel model with the rate parameters of one 
branch all equal to 0, which would indicate that the first calcium ion that binds CaM will always 
bind at one of the two sites, and the other binding site would always bind the second calcium ion 
that arrives. Unsurprisingly, this assumption does not have much validity to it. There is no 
structural or biochemical reason that the first calcium ion coming in would always head to one 
binding site over the other. There is no occlusion of either site in the apo state, and each calcium 
binding loop motif is typical, in the sense that they both have amino acids that can effectively 
coordinate calcium ions without the aid of other structural motifs. Thus, it is clear that the more 
accurate description of calcium binding to CaM is given by a parallel model, even though it is 
more complex than a series model and there is not an effective way to determine a single solution 
to the parameter set. But even within the frame of a parallel model, there are multiple ways that 
these reactions can be described. 
Symmetrical vs. Asymmetrical Models 
 Given a parallel model, there are several parameter sets that can accurately simulate the 
calcium binding properties of the individual domains of CaM. While there are practically an 
infinite number of solutions to the parallel model, some can be narrowed down by thinking 
conceptually and by examining the mathematical relationships between the different parameters. 




asymmetrical. This project has shown that both options are viable for simulating the calcium 
binding properties required of the model, but it is likely that one of the options makes more sense 
conceptually. If a symmetrical model is considered, an implication of this is that both pathways to 
full calcium binding are equal – each calcium binding loop would have the same affinity. This 
assumption is likely to be invalid. The sequences of the two calcium binding loops are not 
identical; thus, it should not be too far-fetched to assume that the affinity of the individual loops 
for calcium are also not identical. Experimental validation for this assumption has been difficult 
to come by given the fleeting nature of single calcium-bound CaM, but efforts have been made 
with mutational and thermodynamic studies. Following mutagenesis and typical 
spectrofluorimetric titrations, it has been demonstrated that the affinity of the two calcium binding 
sites in the N-terminal domain of CaM differ by approximately 1.5-fold (Beccia et al., 2015). 
While it is possible to do a similar analysis with the C-terminal domain using the N98S mutation 
and another mutation in the other calcium binding loop in the C-terminal domain (ex. D130V, 
D132V, or Q136P) given that the N98S mutation appears to knock out a binding site, it is unclear 
if this analysis would work because some of the other mutations can have effects that are more 
drastic than simply knocking out one binding site. Thus, it is unclear if the magnitude of this 
difference translates to the C-terminal domain as well. Nevertheless, these results act as a proof of 
concept at the very least – the two calcium binding loops in either domain of CaM do not have the 
same affinity. Therefore, it is likely that an asymmetric parallel model is a more accurate 
description of calcium binding to CaM than a symmetric parallel model. 
 So, through conceptualization of the calcium binding process the most accurate model has 
been narrowed down to an asymmetric parallel model. But, consistent with the theme of a parallel 




properties of CaM in an asymmetrical manner. There are several questions that can be asked: How 
asymmetrical is the model/what is the magnitude of the difference between branches? Which group 
of parameters should be asymmetrical, or should all of them be asymmetrical? Clearly, there needs 
to be some sort of experimental validation when creating a parallel model. Unfortunately, at this 
moment in time no such experiments have been performed, and it is difficult to even think of a 
method other than potentially some sort of NMR experiment that can be used to uncover 
information about these binding events at such a microscopic level. 
Mathematical Considerations 
 To further characterize the asymmetrical parallel model structure, several different 
asymmetrical models were created (see Figure 13 for two examples). Throughout this process and 
upon analyzing the results, some notable observations were made. Initially, to create an 
asymmetrical model, changes were made to the symmetrical model such that k1,off was decreased 
to increase the affinity for calcium within the first branch and k1,2,on was decreased to decrease the 
affinity for calcium within the second branch. After the initial changes, small tweaks were made 
in these parameters to ensure the affinity and calcium dissociation rate matched the experimental 
data, and k1,on was changed slightly to ensure the calcium association rates could be accurately 
simulated. This approach could be done to make the model as asymmetrical as possible. However, 
it was noted that if this approach was taken, the simulated calcium titration curves began to become 
less steep – the models were losing cooperativity. Because of this, a different approach had to be 
taken to ensure that the cooperativity aspect of the calcium binding is accurate.  
 This is where mathematical relationships between the rate parameters in the parallel model 
can be useful. These mathematical relationships can be derived from the mathematical 




these relationships, there are the microscopic association constants K1 = k1,on/k1,off, K2 = k2,on/k2,off, 
K2,1 = k2,1,on/k2,1,off, and K1,2 = k1,2,on/k1,2,off, and these microscopic association constants are related 
to the macroscopic association constants with the following equations (Linse & Forsén, 1995): 
𝐾 =  
[𝐶𝑎 𝐶𝑎𝑀]
[𝐶𝑎𝑀][𝐶𝑎]
= 𝐾 + 𝐾  




𝐾 ∗ 𝐾 ,
𝐾 + 𝐾
 
Using the first relationship, an asymmetrical model can be built by setting the sum of K1 and K2 
of the symmetrical model equal to the sum of K1 and K2 of the new asymmetrical model and 
solving for a new k1,on after assigning a new k2,on. No matter what value is assigned to k2,on, using 
this relationship to solve for k1,on will give an asymmetrical model that simulates all calcium 
binding properties, including cooperativity. Essentially, as long as k1,on + k2,on is equal to some 
constant, any set of values for those two parameters will work for the model. The same sort of 
relationship is seen with k1,2,off and k2,1,off. As long as those two parameters sum to a constant 
(which in this case is the experimental calcium dissociation rate), the model will accurately 
simulate all of the calcium binding properties of CaM.  
 Interestingly, a similar relationship is not seen between k1,2,on and k2,1,on or between k1,off 
and k2,off. In fact, it has proven to be difficult to determine what relationship there is. Using a 
derivation of the second equation from above leads to a model with slightly altered calcium 
affinity. Other potential relationships such as k1,off * k2,off equaling a constant lead to the same 
outcome – slightly altered affinity. While it is possible to assign a new value to a parameter such 




other calcium binding properties, it is still unclear what the mathematical relationship between 
those two parameters is. 
Slow Skeletal Troponin Insights 
 Although an exact model for the activation of slow skeletal troponin was not able to be 
created, there is still information that can be gathered based on the two models that are proposed. 
Primarily, it is important to note that koff,3 was significantly lower in the slow skeletal model than 
in the cardiac model (by ~6-fold). This implies that the slow skeletal isoform of TnI allows for 
TnC to hold on to its calcium ion much better than the cardiac isoform of TnI. Another potential 
interpretation could be that the initial model for cardiac troponin had a value too high for koff,3, 
because the argument could be made that since the reaction that koff,3 describes is between TnC 
and calcium, koff,3 should be unchanged between the two models since TnC is unchanged between 
the two models. However, this would mean that in order to match the experimental calcium 
dissociation rate for the cardiac troponin complex, the TnI effective concentration would be 
significantly lower than in the slow skeletal troponin complex, which is far-fetched and would 
throw a wrench in the process that was used to make the slow skeletal models to begin with, since 
it was assumed that the TnI effective concentration was saturating in the troponin complex and 
hence the same in the cardiac and slow skeletal isoforms.  
 The other important takeaways from the potential slow skeletal models center around the 
TnI binding step (step 2). Notably, in both potential models, kon,2 is lower than kon,2 in the cardiac 
model. Because the magnitude of the difference between the cardiac kon,2 and the slow skeletal 
values for kon,2 is greater than the potential difference in koff,2, the slow skeletal models indicate 
that the affinity of slow skeletal TnI for TnC is lower than the affinity of cardiac TnI for TnC. But 




concentration of TnI is different in the cardiac thin filament and the slow skeletal thin filament, 
but it is interesting to see that it could be higher or lower, depending on the model. If koff,2 is the 
same as in the cardiac model, then the effective concentration of TnI is higher in the slow skeletal 
thin filament than in the cardiac thin filament. But if koff,2 is slower than the cardiac model, then 
the effective concentration of TnI is lower in the slow skeletal thin filament than in the cardiac thin 
filament. Clearly, even before a model has been concretely determined for the activation of slow 
skeletal troponin, there are many conclusions that can be drawn from the process of creating a 
model that can be of relevance in future studies. 
Troponin Drug Model Takeaways 
 For the model of the activation of cardiac troponin that includes a small molecule, the 
model was used to show how the small molecule can sensitize troponin to calcium by both 
lowering the KD and increasing the maximal activation. It was also used to demonstrate how the 
inhibitory effects of the small molecule were essentially negligible under physiologically relevant 
conditions. This result ends up being significant because it disproves the proposed mechanism of 
the small molecule binding. The mechanism that was initially proposed included the idea that there 
would be a significant inhibitory effect by the small molecule, but with the given rate parameters 
from the characterization of the small molecule the model disproves this theory. This is yet another 
way that the use of models can aid in understanding a biochemical system without performing wet 
lab experiments that would be costly and time consuming. The model allowed for additional 
characterization of the small molecule’s interaction with troponin and vetting of the proposed 





Conclusion & Future Directions 
 In this thesis project it has been demonstrated that mathematical models are both a valid 
approach to understanding and describing biochemical systems and useful to aid in data 
interpretation in a more detailed fashion. These models show that systems that can seem to be 
simple can actually be quite complex and that a lot of detail must go into their descriptions. They 
can demonstrate the impact of a mutation on a protein, they can allow for insight into microscopic 
binding events that differ between proteins, and they can predict and explain experimental data 
with precision. But there are of course other applications of the models presented in this thesis and 
expansions that can be made.  
 For the CaM models, in order to make them more physiologically relevant, they need to 
include more than only one domain of CaM and calcium. Next steps to this project include 
combining models for the C-terminal domain and the N-terminal domain into one model and 
adding one or more target proteins to the model. As discussed earlier, mathematical modeling of 
CaM and its target proteins can lead to important discoveries, even if the models are not as detailed 
as they could be. Creating a model with detailed calcium binding parameters that can answer 
physiologically relevant questions would allow for several important insights to be gained.  
 For the troponin models, the next step would be to experimentally validate which of the 
two slow skeletal models is more accurate by performing the transient occupancy experiments 
described previously and comparing the results from the slow skeletal and cardiac thin filaments. 
These experiments can be done with relative ease and would have been performed with more time. 
Once this has been done, the validated model can be used to answer several questions concerning 




be used to evaluate whether the conclusions based on TnI effective concentration in the cardiac 
model are valid in slow skeletal muscle as well.  
 In sum, this thesis has shown that mathematical modeling is a useful tool for describing 
and understanding biochemical systems, and that this approach shows promise for answering 
future questions. Many questions can be asked and answered using models that can both 
supplement other experimental approaches and be specific to modeling. Due to its relative 
simplicity and powerful abilities, a mathematical model is an approach that should be considered 
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Figure 3. Summary of the model for the C-terminal domain of wild type CaM. (a) Schematic of 
the model with rate parameters, (b) Overlay of real steady-state affinity data with a simulated 
curve, and (c) Overlay of real calcium dissociation data with a simulated curve. 













































Figure 4. Summary of the model for the C-terminal domain of the engineered CaM. (a) 
Schematic of the model with rate parameters, (b) Overlay of real steady-state affinity data with a 
simulated curve, and (c) Overlay of real calcium dissociation data with a simulated curve. 











































Figure 5. Summary of the model for the C-terminal domain of sCaM1. (a) Schematic of the 
model with rate parameters, (b) Overlay of real steady-state affinity data with a simulated curve, 
and (c) Overlay of real calcium dissociation data with a simulated curve. 











































Figure 6. Summary of the model for the C-terminal domain of sCaM4. (a) Schematic of the 
model with rate parameters, (b) Overlay of real steady-state affinity data with a simulated curve, 
and (c) Overlay of real calcium dissociation data with a simulated curve. 











































Figure 7. Summary of the model for the C-terminal domain of N54I CaM. (a) Schematic of the 
model with rate parameters, (b) Overlay of real steady-state affinity data with a simulated curve, 
and (c) Overlay of real calcium dissociation data with a simulated curve. 











































Figure 8. Summary of the model for the C-terminal domain of N98S CaM. (a) Schematic of the 
model with rate parameters, (b) Overlay of steady-state affinity data with simulated curves based 



































Figure 9. Summary of the model for the N-terminal domain of wild type CaM. (a) Schematic of 
the model with rate parameters, (b) Overlay of real steady-state affinity data with a simulated 
curve, and (c) Overlay of real calcium dissociation data with a simulated curve. 











































Figure 10. Summary of the model for the N-terminal domain of sCaM1. (a) Schematic of the 
model with rate parameters, (b) Overlay of real steady-state affinity data with a simulated curve, 
and (c) Overlay of real calcium dissociation data with a simulated curve. 











































Figure 11. Summary of the model for the N-terminal domain of sCaM4. (a) Schematic of the 
model with rate parameters, (b) Overlay of real steady-state affinity data with a simulated curve, 
and (c) Overlay of real calcium dissociation data with a simulated curve. 
































Figure 12. Summary of the symmetrical parallel model for the C-terminal domain of wild type 
CaM. (a) Schematic of the model with rate parameters, (b) Overlay of steady-state affinity data 




















































Figure 13. Summary of two asymmetrical parallel models for the C-terminal domain of wild 
type CaM. (a) Schematic of model one with rate parameters, (b) Schematic of model two with 
rate parameters, (c) Overlay of real steady-state affinity data with a simulate curve from each 
model, (d) Overlay of real calcium dissociation data with a simulated curve from model one, and 






Table 1. Summary of the two potential models for the calcium binding properties of slow 
skeletal troponin. 
Model kon,2 koff,2 [TnI]eff 
Cardiac 9.00 x 107 M-1s-1 110 s-1 12.3µM 
1 2.955 x 107 M-1s-1 110 s-1 26.6µM 









Figure 14. Simulated transient occupancy experiment of the thin filament with different troponin 


















koff,1 = 1900 s
-1
 














































































































































Figure 16. Simulated titration curves of the thin filament with increasing concentrations of the 








Figure 17. Simulated titration curves of the thin filament with increasing concentrations of the 




Table 2. Concentration of the small molecule drug required for the maximum activation of 
troponin at saturating calcium to be 50%, based on the KD of the inhibitory step (binding of the 
drug to the TnC-Ca2+-Closed state), in the thin filament (Low [TnI]) and the troponin complex 
(High [TnI]). 
Inhibitory KD Low [TnI] High [TnI] 
300 µM 376.2 M 9829 M 
30 µM 3.82 M 99.9 M 
3 µM 368 mM 9.98 M 
300 nM 22.9 mM 990 mM 
30 nM 3.68 µM 90.1 mM 
3 nM 658 nM 581 µM 
300 pM 424 nM 1.95 µM 
30 pM 403 nM 631 nM 
 
 
